WEEXA BIOLOGICALS

Active

Private limited companyfounded 2022active for 4 yearsRue Strivay(PLX) 67, 4122 Neupré, BelgiumKBO/BCE: BE 0791.956.795

From the official registers: KBO 3 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

WEEXA BIOLOGICALS has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €88,294 and a net result of -€34,504. Equity is growing by about 33% per year across the filed financial years. Its solvency ranks better than 50% of 145 sector peers (NACE 20, financial year 2025). The computed 12-month bankruptcy probability is 0.6% (low).

Risk analysisFollow Report Compare

WEEXA BIOLOGICALSActiveChecked score 69/100

Risk analysis Report Compare

Official details

KBO

Status: Active since 06-10-2022 Normal situation
Legal form: Private limited company
Registered office: Rue Strivay(PLX) 67, 4122 Neupré
Activity: Manufacture of chemicals and chemical products NACE 20150and 5 others
Establishment unit: 2.336.888.069 5030 Gembloux, since 06-10-2022
Financial year end: 31 December
Peppol: Reachable since 30-10-2025

Company details

Who decides

Board

FW BioconsultDirector · since 05-10-2022 · permanent representative WEEKERS Frédéric
PPP & NPK MANAGEMENTDirector · since 05-10-2022 · permanent representative Xavier VANBEGIN
Agrimo FZE-LLCDirector · since 30-04-2025 · permanent representative Mohamed Salah BEN HAMOUDA

Shareholders

FW Bioconsult33.33%annual accounts 2025

Board & ownership

How it is doing

69 Healthy Checked score 2025

Bankruptcy probabilitywithin 12 months: 0.6%

Annual accounts 2025

Gross margin: -€4,764
Loss: €34,504
Equity: €88,294; ▼ 26.8%
Total assets: €372,118; ▲ 92.9%

Turnover not published (micro format)2025 accounts filed 28 days late

Filed on 28-08-2026at the National Bank

Financials

Why 69raises riskLoss of €34,504 (financial year 2025)Founded in 2022lowers riskLiquidity: current ratio 0.91, cash €117,410Size: total assets €372,118Show the evidence

Checked score

Score 2025

69 / 100

Healthy

Probability in this band: 0.55% to 1.5%

Financially better than 39% of its sector peers (NACE 20, micro)

Every signal that counts is listed under Signals.

Financial strength · tick = 2024

Weak

Solvency 49-39

equity 23.7% of total assets

Liquidity 64-27

short-term debt 49.9% · cash 31.6%

Profitability 7-93

return on assets -9.3%

Bankruptcy probability, 12 months

0.6% Low

0%0.5%1.5%4%10%≥ 25%

About 6 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.4% (355 companies, NACE 20, micro)

Last 24 months 11-2024: 0.4% 12-2024: 0.4%● unchanged vs 11-2024 01-2025: 0.3%▼ -0.1 percentage points vs 12-2024 02-2025: 0.3%● unchanged vs 01-2025 03-2025: 0.3%● unchanged vs 02-2025 04-2025: 0.3%● unchanged vs 03-2025 05-2025: 0.3%● unchanged vs 04-2025 06-2025: 0.3%● unchanged vs 05-2025 07-2025: 0.3%● unchanged vs 06-2025 08-2025: 0.2%▼ -0.1 percentage points vs 07-2025 09-2025: 0.2%● unchanged vs 08-2025 10-2025: 0.2%● unchanged vs 09-2025 11-2025: 0.2%● unchanged vs 10-2025 12-2025: 0.2%● unchanged vs 11-2025 01-2026: 0.2%● unchanged vs 12-2025 02-2026: 0.2%● unchanged vs 01-2026 03-2026: 0.2%● unchanged vs 02-2026 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026 06-2026: 0.2%● unchanged vs 05-2026lowest value 07-2026: 0.2%● unchanged vs 06-2026 08-2026: 0.4%▲ +0.2 percentage points vs 07-2026 09-2026: 0.6%▲ +0.2 percentage points vs 08-2026highest value 10-2026: 0.6%● unchanged vs 09-2026

Credit of up to €6,000 on 30-day terms is acceptable

Liquidity insufficient (current ratio 0.91, compared with 2.84 in 2024, below 1; short-term debt: 49.9% and cash: 31.6% of total assets), and 76.3% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 20, micro): better than 40% on solvency, 69% on liquidity, 26% on profitability and 21% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.

lowers riskraises risk

Loss of €34,504 (financial year 2025)

NBB · annual accounts

Liquidity: current ratio 0.91, cash €117,410

NBB · annual accounts

Size: total assets €372,118

Companies of this size fail less often; how much that weighs depends on the rest of its profile.

NBB · annual accounts

Founded in 2022

Companies of this age fail more often than older ones; how much that weighs depends on the rest of its profile.

KBO

2025 accounts filed 28 days late

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-08-2026, 28 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.

NBB · 3 filings

Deviation from the deadline

2025

28 days late

2024

37 days early

2023

6 days early

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 3 accounts on average 5 days before the deadline; the sector median (NACE 20) for financial year 2024 is 22 days before the deadline, and 26% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 26 July (3 of the last 3 filed years within 33 days of that day).

Companies Code · seven months

Where today falls in the filing period

01-11-2026 today31-12-2026 year end31-07-2027 deadline

No strike-offs in the KBO publications

Searched since incorporation in 2022.

KBO publications · our coverage

Key points

Caution: From profit to loss in 2025after €49,110 in 2024 -€34,504 View
Caution: Among the weakest 17% on net resultsector median €143 · 146 companies -€34,504 View

Documents

Key facts about WEEXA BIOLOGICALS

What is the company number of WEEXA BIOLOGICALS?: 0791.956.795. In Belgium the VAT number is the company number with BE in front: BE 0791.956.795.
Where is WEEXA BIOLOGICALS based?: The registered office is at Rue Strivay(PLX) 67, 4122 Neupré.Company details
What does WEEXA BIOLOGICALS do?: According to the KBO register, the main activity is manufacture of chemicals and chemical products (NACE 20150).
What is the legal form of WEEXA BIOLOGICALS?: Private limited company (BV).
When was WEEXA BIOLOGICALS founded?: On 06-10-2022.
Is WEEXA BIOLOGICALS still active?: Yes, WEEXA BIOLOGICALS is an active enterprise in the KBO register.
What is the turnover of WEEXA BIOLOGICALS?: The annual accounts for financial year 2025 state no turnover: the micro format does not require it.Financials
Is WEEXA BIOLOGICALS profitable?: In financial year 2025, WEEXA BIOLOGICALS made a loss of €34,504.
Where can I find the annual accounts of WEEXA BIOLOGICALS?: WEEXA BIOLOGICALS filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of WEEXA BIOLOGICALS due?: By 31-07-2027, for financial year 2026.Timeline